Fresenius Kabi

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2025–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	6	2
2025	—	8	2

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
S-3 GROUP	—	8
EAST END GROUP, LLC	—	6

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	11
SENATE	11
Commerce, Dept of (DOC)	4
Health & Human Services, Dept of (HHS)	4
White House Office	4

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	13
Copyright/Patent/Trademark	Copyright/Patent/Trademark	8
Tariff (miscellaneous tariff bills)	Tariff (miscellaneous tariff bills)	5
Manufacturing	Manufacturing	5

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 3269119th Congress

ETHIC Act

2026 · third_quarter · Firm: S-3 GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: HR 3269

H.R. 3269119th Congress

ETHIC Act

2026 · third_quarter · Firm: S-3 GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: HR 3269

S. 2276119th Congress

ETHIC Act

2026 · third_quarter · Firm: S-3 GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: S. 2276

S. 2276119th Congress

ETHIC Act

2026 · third_quarter · Firm: S-3 GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: S. 2276

Show 21 more cited filings

S. 2658119th Congress

Medication Affordability and Patent Integrity Act

2026 · third_quarter · Firm: S-3 GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: S. 2658

S. 2658119th Congress

Medication Affordability and Patent Integrity Act

2026 · third_quarter · Firm: S-3 GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: S. 2658

H.R. 3269119th Congress

ETHIC Act

2026 · second_quarter · Firm: S-3 GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: HR 3269

H.R. 3269119th Congress

ETHIC Act

2026 · second_quarter · Firm: S-3 GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: HR 3269

S. 2276119th Congress

ETHIC Act

2026 · second_quarter · Firm: S-3 GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: S. 2276

S. 2276119th Congress

ETHIC Act

2026 · second_quarter · Firm: S-3 GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: S. 2276

S. 2658119th Congress

Medication Affordability and Patent Integrity Act

2026 · second_quarter · Firm: S-3 GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: S. 2658

S. 2658119th Congress

Medication Affordability and Patent Integrity Act

2026 · second_quarter · Firm: S-3 GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: S. 2658

H.R. 3269119th Congress

ETHIC Act

2026 · first_quarter · Firm: S-3 GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: HR 3269

H.R. 3269119th Congress

ETHIC Act

2026 · first_quarter · Firm: S-3 GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: HR 3269

S. 2276119th Congress

ETHIC Act

2026 · first_quarter · Firm: S-3 GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: S. 2276

S. 2276119th Congress

ETHIC Act

2026 · first_quarter · Firm: S-3 GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: S. 2276

S. 2658119th Congress

Medication Affordability and Patent Integrity Act

2026 · first_quarter · Firm: S-3 GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: S. 2658

S. 2658119th Congress

Medication Affordability and Patent Integrity Act

2026 · first_quarter · Firm: S-3 GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: S. 2658

H.R. 3269119th Congress

ETHIC Act

2025 · fourth_quarter · Firm: S-3 GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: HR 3269

H.R. 3269119th Congress

ETHIC Act

2025 · fourth_quarter · Firm: S-3 GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: HR 3269

S. 2276119th Congress

ETHIC Act

2025 · fourth_quarter · Firm: S-3 GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: S. 2276

S. 2276119th Congress

ETHIC Act

2025 · fourth_quarter · Firm: S-3 GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: S. 2276

S. 2658119th Congress

Medication Affordability and Patent Integrity Act

2025 · fourth_quarter · Firm: S-3 GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: S. 2658

S. 2658119th Congress

Medication Affordability and Patent Integrity Act

2025 · fourth_quarter · Firm: S-3 GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: S. 2658

H.R. 3269119th Congress

ETHIC Act

2025 · third_quarter · Firm: S-3 GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: HR 3269

Source: Senate LDA

Fresenius Kabi — Lobbying Disclosure | Poliscope